Mosby's 2026 Nursing Drug Reference - Elsevier E-Book on VitalSource, 39th Edition

by Linda Skidmore-Roth, RN, MSN, NP

Elsevier eBook on VitalSource

ISBN: 9780443282805

Publication Date: 05-07-2025

Page Count: 1360

Imprint: Mosby

List Price: $41.99

Was $41.99

Now $36.95

Or $0.00 with a valid access code

**Selected for 2025 Doody’s Core Titles® with "Essential Purchase" designation in Pharmacology**

Choose the drug handbook trusted by nurses for over 35 years! Mosby's 2026 Nursing Drug Reference makes it easy to find the most vital information on the drugs you administer most frequently. More than 5,000 drugs are profiled — including 24 new entries for drugs recently approved by the FDA. And no other drug guide places a higher emphasis on patient safety, with Black Box Warnings for dangerous adverse reactions, High Alerts for drugs with the greatest risk, and a focus on both common and life-threatening side effects. From nursing pharmacology expert Linda Skidmore-Roth, this annual bestseller proves there is a difference in drug guides.

Related Products
- 39th Edition
  Evolve Resources for Mosby's 2026 Nursing Drug Reference
  Resources
  
  ISBN: 9780443282829
Key Features
- NEW! Drug monographs for 24 newly released, FDA-approved medications equip you with the latest drug information including generic names, trade names, pronunciations, do-not-confuse drugs, action, uses, contraindications, precautions, dosages and routes, side effects, pharmacokinetics, interactions (including drug/herb, drug/food and drug/lab test), nursing considerations, treatment of overdose, patient/family teaching, and more
- NEW! Several online-only drug monographs are added to the companion Evolve website, creating an overall total of more than 100 Evolve-only drug monographs for lesser-used medications
- NEW! Combinations heading for selected monographs highlight common combinations
- More than 5,000 generic and trade-name drugs are profiled, covering almost every drug you will administer in practice or in clinicals
- Alphabetical organization by generic name provides quick and easy access to specific drugs, with both trade and generic names listed in the index
- Bolded coverage of IV drug administration highlights dosage and IV administration instructions, including safety considerations and Y-site, syringe, and additive compatibilities
- Nursing Process steps are used as the framework for organizing all nursing care information
- Complete pharmacokinetic information is summarized in a table and includes the mechanism and absorption of the drug as well as its action, duration, and excretion
- Side effects information is organized by body system and identified as common or life threatening, showing signs to watch for during assessments
- High Alert headers highlight drugs that pose the greatest risk if administered improperly
- Black Box Warnings provide alerts to FDA warnings of dangerous or life-threatening drug reactions
- Overview of drug categories explains the safe administration of common classes of drugs, as well as their common side effects and interactions
- Flexible, water-resistant cover provides durability in the clinical setting
Contents

INDIVIDUAL DRUG MONOGRAPHS

APPENDICES
- A. Selected New Drugs
- B. Ophthalmic, Nasal, Topical, and Otic Products
- C. Vaccines and Toxoids
- D. Recent FDA Drug Approvals

INDEX

EVOLVE WEBSITE
- Additional Monographs
- Drug Categories
Authors

Linda Skidmore-Roth, RN, MSN, NP, Consultant, Littleton, Colorado; Former Nursing Faculty, New Mexico State University, Las Cruces, New Mexico; El Paso Community College, El Paso, Texas, USA
Accessibility
- Ways of Reading
  - The appearance of the text and page layout can be modified according to the capabilities of the reading system (font family and font size, spaces between paragraphs, sentences, words, and letters, as well as color of background and text)
  - This e-publication is accessible to the full extent that the file format and types of content allow, on a specific reading device, by default, without necessarily including any additions such as textual descriptions of images or enhanced navigation
  - No information about nonvisual reading is available
- Conformance
  - For detailed accessibility information, see Elsevier's website at https://www.elsevier.com/about/accessibility
  - For queries regarding accessibility information, contact [email protected]
  - The publication was certified on 18-11-2025
- Navigation
  - Table of contents to all chapters of the text via links
- Rich Content
  - No information is available
- Hazards
  - No information is available
- Product Content
  - No information is available
- Legal Considerations
  - No information is available
- Additional Accessibility Information
  - For readers with color vision deficiency, use of color (e.g., in diagrams, graphics and charts, in prompts, or on buttons inviting a response) is not the sole means of graphical distinction or of conveying information
  - E-publication includes basic navigation (usually less detailed than TOC-based navigation)
  - Where links, controls or buttons are included in the content, the purpose or functionality of each link, control or button is apparent from the associated text alone - or where it is unclear, separate link, control or button descriptions are provided
  - All (or substantially all) textual matter is arranged in a single logical reading order (including text that is visually presented as separate from the main text flow, e.g., in boxouts, captions, tables, footnotes, endnotes, citations, etc.). Non-textual content is also linked from within this logical reading order. (Purely decorative non-text content can be ignored).
  - The language of the text has been specified (e.g., via the HTML or XML lang attribute) to optimise text-to-speech (and other alternative renderings), both at the whole document level and, where appropriate, for individual words, phrases or passages in a different language.